Consistent with our results, JAK2i have been shown in other studies to have no significant effect on effector T cell reactivity in a mouse model of graft-versus-host disease, indicating that JAK2 plays little (if any) role in effector T cell function (37). Here, JAK2 is linked to graft versus host disease.